Coronavirus

Last Modified:

The latest news and announcements from Emory University and Emory Healthcare about coronavirus.

Media Contacts

Janet Christenbury
404-727-8599 
jmchris@emory.edu

Jill Wu
404-727-3870 
jill.s.wu@emory.edu 

Story Hub photo

Featured Stories »

Emory experts available to discuss COVID-19

Emory experts available to discuss COVID-19

Emory has a number of faculty members and health care professionals who can speak about many facets of the COVID-19 outbreak.

woman receiving vaccination

Emory experts available to answer questions on FDA approval of COVID-19 vaccines

The U.S. Food and Drug Administration (FDA) has approved Pfizer-BioNTech’s COVID-19 vaccine. Emory experts are available to discuss the FDA approval announcement as well as all the other ways COVID-19 continues to impact us all.

Screen shot of Facebook Live event

What full FDA approval of Pfizer’s vaccine means for the future of the pandemic

In a conversation recorded Aug. 24, 2021, Emory infectious disease experts Aneesh Mehta and Colleen Kelley answer questions about FDA approval COVID-19 vaccines, virus variants, masking and more.

Vaccination

Emory research contributions built path to COVID-19 vaccine

Emory researchers have been involved in testing all three of the COVID-19 vaccines currently in use in the United States, along with others that may play important roles in the future.

COVID virus

COVID-19 survivors may possess wide-ranging resistance to the disease

Recovered COVID-19 patients retain broad and effective longer-term immunity to the disease, suggests a recent Emory University study, which is the most comprehensive of its kind so far. The findings have implications for expanding understanding about human immune memory as well as future vaccine development for coronaviruses.

George Painter, PhD, CEO of Emory's DRIVE

Antiviral drug invented by Emory’s DRIVE licensed in India for COVID-19 emergency

To address the intensifying COVID-19 crisis in India, the pharmaceutical company Merck has agreed to facilitate the manufacture and distribution of molnupiravir, an investigational antiviral drug that was discovered at Emory.

Virus

How two SARS-CoV-2 variants affect antibodies from vaccines

A more contagious coronavirus variant known as B.1.1.7 is still susceptible to antibodies induced after COVID-19 infection or vaccination. But another called B.1.351 modestly reduces antibodies' potency.

Map of the United States

New Georgia COVID-19 data adds important local dimension to national tracking tool

Emory University researchers have enhanced their dynamic national COVID-19 Health Equity Dashboard to provide more localized information on the impact of the pandemic in communities across Georgia.

George Painter

Drug launched at Emory reduces virus that causes COVID-19 to undetectable levels

An antiviral drug initially discovered by Emory’s non-profit drug development company DRIVE appears safe and reduces SARS-CoV-2 to undetectable levels in COVID-19 patients after five days of administration, according to data from a Phase II clinical trial.

Pregnant woman

Transfer of COVID-19 antibodies from pregnant women to newborns lower than expected

Women who contract COVID-19 during pregnancy are able to make strong neutralizing antibodies but may end up passing fewer of these protective antibodies to their infants than desired, a new study at Emory University shows.

Human chromosomes

International study finds increased COVID-19 mortality among adults with Down syndrome

Emory University researchers, in an international collaboration with the Trisomy 21 Research Society (T21RS), have found increased COVID-19 mortality among those with Down syndrome.

Researcher demonstrating equipment

NIH grant funds Emory work on indoor air sensor for SARS-CoV-2

Emory University received a National Institutes of Health grant, for a total of $883,000 over two years, to develop a sensor capable of detecting SARS-CoV-2 in the air of indoor spaces.

 Man and woman relaxing outdoors

The Two Traumas

In 2020, Dr. Kevin L. Gilliam II and Dr. Iesha Galloway-Gilliam found themselves athe the collision point of health and social justice.

Man receiving an injestion

Emory begins Phase 3 study of Novavax COVID-19 vaccine

Emory University is participating in a new Phase 3 vaccine clinical trial for COVID-19. The clinical trial will test the safety and effectiveness of an investigational protein-based vaccine developed by U.S. biotechnology company Novavax, Inc.

Woman receives COVID vaccine

Emory Healthcare administers first COVID-19 vaccinations to its frontline health care workers

On Dec. 17, Emory Healthcare administered the first COVID-19 vaccinations to its frontline health care workers, beginning with an emergency room nurse, providing hope as the pandemic continues to surge across Georgia and the U.S.

Scientist conducting test

Baricitinib speeds COVID-19 recovery in NIAID trial

Emory investigators contributed to a randomized, controlled trial of more than 1,000 adults hospitalized with COVID-19 pneumonia. The study showed that treatment with the anti-inflammatory drug baricitinib resulted in faster recovery and a greater likelihood of clinical improvement, when combined with remdesivir.

Illustration of man in the woods

Valuing 'natural capital' vital to avoid next pandemic, global experts warn

Pandemics will emerge more often, kill more people than COVID-19 and do even more damage to the world economy unless urgent steps are taken to address risk drivers such as deforestation, warns a major new report on biodiversity and pandemics.

cpage_moderna_success.jpg

Vaccine tested at Emory highly effective in preventing COVID-19, study says

An investigational vaccine tested at Emory is 94.5 percent effective at preventing COVID-19, according to early results from a large-scale clinical trial.

Visitor from Operation Warp Speed

Warp Speed chief visits Emory, urges participation in COVID vaccine trials

Operation Warp Speed's Chief Science Advisor visited Emory University and urged Americans to continue enrolling in ongoing COVID-19 vaccine trials.

cpage_vaccine_trial.jpg

Emory begins advanced stage clinical trial for another COVID-19 vaccine

Emory University will enroll adult volunteers in a large-scale clinical trial designed to evaluate whether a single dose of an investigational vaccine can prevent symptomatic COVID-19.

npage_covid_orange.jpg

Emory helps establish national standard of care for COVID-19 treatment

Final results of an international study on adults hospitalized with COVID-19 show that treatment with the experimental antiviral drug remdesivir resulted in faster recovery, fewer days on oxygen and lower progression to ventilation compared with placebo.

Virus

Monoclonal antibodies for COVID-19: Emory experts explain experimental treatment

Giving a COVID-19 patient a monoclonal antibody is a short cut: providing the body what another immune system — and researchers — have already refined and optimized.

cpage_lam.jpg

Emory shares in $18.2 million NIH award to continue work on COVID-19 tests

Emory, Children’s Healthcare of Atlanta and Georgia Tech have joined forces to evaluate COVID-19 diagnostic tests. The federally-funded project will lead to at-home and other point-of-care COVID tests that could provide results in minutes.

Illustration of brain

Unexplained strokes, delayed symptoms recognition found in study on COVID-19 and ischemic stroke

In a case series study that explored the association of COVID-19 and acute ischemic stroke, researchers at Emory University Hospital observed higher than expected rates of unexplained or “cryptogenic” strokes, as well as delays in stroke presentations or symptom recognition.

cpage_vaccine_phase3.jpg

Phase III of COVID-19 vaccine trial launches at Emory

Emory University is taking part in Phase 3 of a nationwide clinical trial designed to evaluate an investigational vaccine for COVID-19. Emory administered its first dose of the vaccine at the Hope Clinic of Emory Vaccine Center this week.

cpage_vaccine_trial.jpg

COVID-19 vaccine tested at Emory is safe, generates immune response, early results show

An investigational vaccine designed to protect against COVID-19 was generally well tolerated and resulted in production of both binding and neutralizing antibodies in healthy adult volunteers, according to early results of an ongoing phase 1 trial.

More News »

Research roundup: Recent grants and publications for Emory faculty and staff

Sep. 21, 2021

Pfizer says COVID-19 vaccine safe, spurs immune response in kids ages 5 to 11

Sep. 21, 2021

Explaining COVID-19 breakthrough infections

Sep. 21, 2021

The difference between COVID-19 ‘third doses’ and ‘boosters’

Sep. 10, 2021

Emory partners with Atlanta mayor’s office to provide COVID-19 vaccines in Piedmont Park

Sep. 9, 2021

With FDA approval of Pfizer COVID-19 vaccine, vaccinations remain top of mind for metro Atlanta health care systems

Aug. 26, 2021

What full FDA approval of Pfizer’s vaccine means for the future of the pandemic

Aug. 26, 2021

Emory research contributions built path to COVID-19 vaccine

Aug. 26, 2021

Emory experts available to answer questions on FDA approval of COVID-19 vaccines

Aug. 23, 2021

Baricitinib, first tested at Emory against COVID-19, emerges as major treatment option

Aug. 10, 2021

Emory to require faculty and staff COVID-19 vaccinations for fall 2021

July 27, 2021

COVID-19 survivors may possess wide-ranging resistance to the disease

July 22, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

July 20, 2021

COVID-19 vaccine antibodies weaker vs. Delta/Kappa viral variants

July 13, 2021

‘Emory Inspired’: Emory mobilizes COVID-19 vaccinations

July 6, 2021

The way forward: Bridging the divide

July 6, 2021

MOMI-Vax study evaluates COVID-19 vaccination during pregnancy and postpartum

July 6, 2021

The way forward: Rebounding from a wrecked economy

June 29, 2021

Emory University researchers awarded NIH grant to conduct COVID-19 surveillance through detection of SARS Coronavirus-2 in wastewater

June 24, 2021

The way forward: Sparking educational evolution

June 21, 2021

Emory testing 'mix and match' booster shots for COVID-19 vaccines

June 15, 2021

The way forward: Preparing for the next pandemic

June 14, 2021

Emory joins COVID-19 College Challenge, part of White House ‘National Month of Action’

June 3, 2021

President Fenves announces updates to Emory's COVID-19 protocols

June 3, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

May 25, 2021

Through Council on Competitiveness, Emory takes role in increasing American innovation

May 20, 2021

A ‘heart’ for health, justice and helping others

May 7, 2021

Emory, Children’s Healthcare of Atlanta launch COVID-19 vaccine trial for young children

May 7, 2021

Emory testing next-generation COVID-19 vaccines

May 5, 2021

‘Batgirl’ takes on new discoveries in disease ecology, rabies transmission

April 27, 2021

Antiviral drug invented by Emory’s DRIVE licensed in India for COVID-19 emergency

April 27, 2021

COVID-19 Community Update: Immunization required for Emory students in fall

April 22, 2021

Emory to require student COVID-19 vaccinations for fall 2021

April 19, 2021

New Georgia COVID-19 data adds important local dimension to national tracking tool

April 14, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

April 13, 2021

April 8 COVID-19 Community Update: Progression to “yellow” status

April 8, 2021

Emory part of consortium developing model of care plan for future pandemics

April 6, 2021

Emory senior helps develop COVID-19 Health Equity Dashboard

April 5, 2021

Emory participating in Moderna COVID-19 variant vaccine study

April 1, 2021

Emory Healthcare administers 100,000 doses of COVID-19 vaccine

March 25, 2021

COVID-19 experiment finds promising government strategies for community engagement

March 25, 2021

March 24 COVID-19 Community Update: Expanded vaccine eligibility

March 24, 2021

How two SARS-CoV-2 variants affect antibodies from vaccines

March 22, 2021

Drug launched at Emory reduces virus that causes COVID-19 to undetectable levels

March 17, 2021

Transfer of COVID-19 antibodies from pregnant women to newborns lower than expected

March 15, 2021

Study shows community exposure as greatest risk of COVID-19 infection in health care workers, not health care setting

March 11, 2021

Emory epidemiologist braves Alaskan tundra for COVID-19 testing at Iditarod

March 11, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

March 11, 2021

COVID-19: One year later

March 10, 2021

'Fighting for my family'

March 9, 2021

March 9 COVID-19 Community Update: Changes to Georgia’s vaccine distribution plan and Emory’s response

March 9, 2021

COVID-19 antibody study: 1/8 in USA infected by October 2020

March 8, 2021

Vote for Emory in STAT Madness and give COVID-19 a one-two punch!

March 1, 2021

Feb. 24 COVID-19 Community Update: How Emory is helping lead vaccine efforts

Feb. 24, 2021

International study finds increased COVID-19 mortality among adults with Down syndrome

Feb. 22, 2021

Emory, Curry College researchers examine role of COVID-19 antibodies on reinfection

Feb. 19, 2021

Rouphael appointed Hope Clinic executive director

Feb. 15, 2021

NIH grant funds Emory work on indoor air sensor for SARS-CoV-2

Feb. 15, 2021

Emory and Georgia Tech students join forces to ‘Hack COVID-19’

Feb. 10, 2021

Emory launches new vaccination tracker as part of its online health equity dashboard

Feb. 10, 2021

Feb. 9 COVID-19 Community Update: Vaccines and variants

Feb. 9, 2021

Healing our 'two traumas'

Feb. 9, 2021

COVID-19 missteps could be used to help strengthen science and public health, experts say

Feb. 9, 2021

SARS-CoV-2 variants: CDC, private foundations support genomic surveillance

Feb. 5, 2021

Emory expanding post-COVID clinics for 'long haulers'

Feb. 5, 2021

Emory-developed COVID-19 vaccine safe, effective in animal models

Feb. 4, 2021

Atlanta Falcons invite local health care heroes to attend Super Bowl LV

Feb. 3, 2021

COVID-19 Community Update: Feb. 3, 2021

Feb. 3, 2021

Community exposure, Black race help predict health care worker risk for positive COVID-19 antibody tests

Feb. 2, 2021

Research roundup: Recent grants and publications for Emory faculty and staff

Jan. 25, 2021

Virtual town hall highlights COVID-19 vaccine news

Jan. 25, 2021

Presidential inauguration features boy who played trumpet to inspire health care workers

Jan. 20, 2021

WHO, Emory experts discuss COVID-19 challenges in Facebook Live event

Jan. 14, 2021

Just another common cold virus? Modeling SARS-CoV-2’s future fade

Jan. 12, 2021

Emory ranks 5th among U.S. universities for infectious diseases program

Jan. 12, 2021

Emory begins Phase 3 study of Novavax COVID-19 vaccine

Dec. 29, 2020

Emory Healthcare administers first COVID-19 vaccinations to its frontline health care workers

Dec. 17, 2020

Emory University hosts COVID-19 vaccine town hall

Dec. 17, 2020

2020 in review: Photos from the pandemic

Dec. 16, 2020

Our stories of resilience and resolve

Dec. 15, 2020

Baricitinib speeds COVID-19 recovery in NIAID trial

Dec. 14, 2020

COVID-19 vaccine rollout demands 'unprecedented' level of communication with U.S. public

Dec. 10, 2020

Free COVID-19 test offered as part of Emory research study

Dec. 9, 2020

Valuing 'natural capital' vital to avoid next pandemic, global experts warn

Dec. 1, 2020

Emory Healthcare joins major health systems across U.S. in #MaskUp campaign

Nov. 20, 2020

Vaccine tested at Emory highly effective in preventing COVID-19, study says

Nov. 17, 2020

Warp Speed chief visits Emory, urges participation in COVID vaccine trials

Nov. 13, 2020

Return to sports after COVID-19: cardiologists’ recommendations

Nov. 9, 2020

EmoryTogether Fund now accepting applications

Nov. 6, 2020

Emory begins advanced stage clinical trial for another COVID-19 vaccine

Oct. 29, 2020

Research roundup: Recent grants and publications for Emory faculty and staff

Oct. 29, 2020

Emory helps establish national standard of care for COVID-19 treatment

Oct. 15, 2020

Emory Community Compact: Meet students and staff helping Emory beat COVID-19

Oct. 15, 2020

Monoclonal antibodies for COVID-19: Emory experts explain experimental treatment

Oct. 13, 2020

More than $18,000 in devices donated to Emory Saint Joseph’s Hospital, helping connect patients with family

Oct. 12, 2020

Immune cell activation in severe COVID-19 resembles lupus

Oct. 7, 2020

Emory student receives fellowship grant for humanities work

Oct. 6, 2020

Emory shares in $18.2 million NIH award to continue work on COVID-19 tests

Oct. 5, 2020

Learn how Emory Libraries found creative solutions during the pandemic

Oct. 1, 2020

COVID-19 vaccine tested at Emory spurs immune response in older adults

Sep. 29, 2020

Unexplained strokes, delayed symptoms recognition found in study on COVID-19 and ischemic stroke

Sep. 21, 2020

Emory, Fulton County study shows importance of proactive COVID-19 testing to prevent further infection

Sep. 17, 2020

Emory's Center for the Study of Human Health hosts author Q&A series

Sep. 17, 2020

High antiviral antibody levels may herald pediatric COVID-19 complication

Sep. 8, 2020

New Synergy awardees represent spirit of partnership in COVID-19 research

Sep. 4, 2020

Message from President Fenves: COVID-19 tracking and community update

Aug. 28, 2020

Help slow the spread of COVID-19 'For You. For Us. For Emory.'

Aug. 27, 2020

Emory experts to discuss COVID-19 health concerns among minorities

Aug. 25, 2020

Emory professor’s podcast honors civil rights ‘cold case’ widow

Aug. 6, 2020

Medical students help deliver COVID-19 research through infographics

July 16, 2020

Admission team works to ‘get the Emory spirit into the virtual world’

July 13, 2020

Emory libraries reopen on appointment-only basis effective July 6

July 2, 2020

World Zoonoses Day: 'We have to act now to avoid even bigger catastrophes'

July 2, 2020

Emory team brings COVID-19 testing, education to poultry workers in rural Ga.

July 1, 2020

Virtual town hall answers student questions about fall return to Emory campus

June 26, 2020

Cleaning tips from a chemist who researches disinfectants

June 23, 2020

Emory, state of Georgia collaborate on COVID-19 response

June 16, 2020

COVID-19 research: Emory’s work spans the gamut, from bench to bedside

June 12, 2020

Emory announces plans for fall semester

June 11, 2020

First-year students' stories of a pandemic: Study seeks data to help them flourish

June 4, 2020

Behavioral studies in era of COVID-19 raise new concerns about diversity

May 26, 2020

All Hands on Deck: The Zoom experts

May 26, 2020

'Health Behind Locked Doors' course explores incarceration, institutionalization

May 26, 2020

Emory community shares 'Stories from the Pandemic'

May 26, 2020

Video: Coronavirus and Emory

Feb. 18, 2020